Company / Free Cash Flow per Share
Kodiak Sciences Inc. Free Cash Flow per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.24
FY2024
5-year range
-$4.66 / -$1.91
FY2020-FY2024
Trend
+40.0%
vs FY2023
Sector context
#135 of 190
Health Care
What the data says
At $-2.24, Kodiak Sciences Inc.'s free cash flow per share ranks #135 of 190 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 9 years, ranging from $-4.66 in FY2022 to $-1.05 in FY2019.
Based on SEC 10-K filings.
-2.24 in FY2024.
Improved from $-4.66 to $-2.24 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#135 of 190 in Health CareTop 71% of 190This company -$2.24 Sector average $3.32
▼
-167.3% below sector average
Key checks
Key Insights
- In FY2024, free cash flow per share increased 40.0% year-over-year.
- Ranks #135 out of 190 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2019.
- Lowest free cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$2.24 | +40.0% |
| FY2023 | -$3.73 | +19.9% |
| FY2022 | -$4.66 | -21.1% |
| FY2021 | -$3.85 | -101.8% |
| FY2020 | -$1.91 | -82.4% |
| FY2019 | -$1.05 | +46.2% |
| FY2018 | -$1.94 | +18.2% |
| FY2017 | -$2.38 | -1.9% |
| FY2016 | -$2.33 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026